Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
- License Information
-
More Information
Article History
Received: 19 October 2023
Accepted: 26 December 2023
First Online: 20 January 2024
Declarations
:
: Dirk Dressler: DD received honoraria for services provided to Allergan, Ipsen, Merz, Lanzhou Institute of Biological Products, Medy-Tox, Revance, Desitin, Syntaxin, AbbVie, Medtronic, St Jude, Boston Scientific, Almirall, Bayer, Sun, Teva, UCB, IAB-Interdisciplinary Working Group for Movement Disorders. He is shareholder of Allergan and holds patents on botulinum toxin and botulinum toxin therapy. Bruno Kopp: BK has nothing to declare. Lizhen Pan: LP has nothing to declare. Fereshte Adib Saberi: FAS is founder and owner of IAB—Interdisciplinary Working Group for Movement Disorders. She received reimbursement from Abbot, AbbVie, Almirall, Allergan, Bayer, Desitin, Dynamed, Hempel GesundheitsPartner, Ipsen, Johnson & Johnson, Licher, Meda, Medtronic, Merz, Orion, PTZ Nawrath, Sensomotorik and Rehabilitation Hellmuth and Thiel, Sintetica, Sporlastic, Sun, Teva, Tricumed, TRS Med, UCB.
: The study was performed under the regulations of the local ethical committee of Hannover Medical School.
